Soleno Therapeutics (SLNO) Liabilities from Discontinued Operations (2016 - 2018)

Soleno Therapeutics (SLNO) has 3 years of Liabilities from Discontinued Operations data on file, last reported at 110000.0 in Q3 2018.

• Liabilities from Discontinued Operations for Q3 2018 came in at 110000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2018 was 110000.0 (changed N/A YoY), and the FY2017 annual result was 225000.0, up 177.78% from the prior year.
• Liabilities from Discontinued Operations improved to 110000.0 in Q3 2018 per SLNO's latest filing, from 102000.0 in the prior quarter.
• Over five years, Liabilities from Discontinued Operations peaked at 625000.0 in Q1 2018 and troughed at 81000.0 in Q4 2016.
• A 3-year average of 228600.0 and a median of 110000.0 in 2018 frame the typical range for Liabilities from Discontinued Operations.
• On a YoY basis, Liabilities from Discontinued Operations climbed as much as 177.78% in 2017 and fell as far as 177.78% in 2017.
• A 3-year view of Liabilities from Discontinued Operations shows it stood at 81000.0 in 2016, then soared by 177.78% to 225000.0 in 2017, then plunged by 51.11% to 110000.0 in 2018.
• Business Quant data shows SLNO's Liabilities from Discontinued Operations at 110000.0 in Q3 2018, 102000.0 in Q2 2018, and 625000.0 in Q1 2018.